Effect of cholesterol and triglyceride increases on time to progression in renal clear cell cancer patients treated with everolimus.

e15528 Background: An increased level of cholesterolemia (C) and triglyceridemia (T) secondary to an impairment of lipidic metabolism is a well known side effect of all mTOR inhibitors including ev...